Nxera Pharma Co أخبار Eulerpool

Nxera Pharma Co إيولربول AFX

أخبار سهم Nxera Pharma Co

يتابع Nxera Pharma Co العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Nxera Pharma Co.

• ٩ يوليو ·

  Yahoo
  Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results
• ٩ يوليو ·

  SeekingAlpha
  Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth
• ٢٧ يونيو ·

  Yahoo
  Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
• ١٨ يونيو ·

  Yahoo
  Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
• ٣٠ مايو ·

  Yahoo
  Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
• ٣٠ مايو ·

  Yahoo
  Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
• ٩ مايو ·

  Yahoo
  Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
• ٩ مايو ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024
• ١٧ أبريل ·

  Yahoo
  Nxera Pharma: Notice of Issuance of New Shares Under the Restricted Stock Unit (RSU) Plan and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Previous Years’ RSU Plan
• ١٦ أبريل ·

  Yahoo
  Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568